Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Olanzapine

A S Hale1

  • 1Kent Institute of Medicine and Health Science, University of Kent at Canterbury.

British Journal of Hospital Medicine
|June 10, 1998
PubMed
Summary
This summary is machine-generated.

Olanzapine, a new atypical neuroleptic, matches haloperidol for positive schizophrenia symptoms but excels in negative symptoms with fewer movement side effects. Common side effects include drowsiness and weight gain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coagulation factor and hemostatic protein content of canine plasma after storage of whole blood at ambient temperature.

Journal of veterinary internal medicine·2014
Same author

Critical flicker fusion threshold and anticholinergic effects of chronic antidepressant treatment in remitted depressives.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Detoxified alcoholics, major depressives and tyramine sulphate excretion.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Lack of evidence of pregnancy-induced alloantibodies in dogs.

Journal of veterinary internal medicine·2009
Same author

Collection and preparation of blood products.

Clinical techniques in small animal practice·2004
Same author

Erotomania induced by venlafaxine: a case study.

Acta psychiatrica Scandinavica·2003
Same journal

The autopsy in the 1990s.

British journal of hospital medicine·1999
Same journal

Screening for breast cancer.

British journal of hospital medicine·1999
Same journal

Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.

British journal of hospital medicine·1999
Same journal

Liposarcoma: a review of current diagnosis and management.

British journal of hospital medicine·1999
Same journal

How to do it in surgery: laparoscopic rectopexy.

British journal of hospital medicine·1999
Same journal

The management of ovarian cancer.

British journal of hospital medicine·1999
See all related articles

Area of Science:

  • Psychopharmacology
  • Neuroscience
  • Clinical Psychiatry

Background:

  • Olanzapine is a novel atypical neuroleptic agent.
  • It exhibits a receptor binding profile comparable to clozapine.
  • Schizophrenia treatment remains a significant clinical challenge.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of olanzapine in schizophrenia.
  • To compare olanzapine's effectiveness against positive and negative symptoms with haloperidol.
  • To assess the side effect profile of olanzapine, particularly extrapyramidal symptoms.

Main Methods:

  • Clinical trial comparing olanzapine and haloperidol.
  • Assessment of positive and negative symptom scores.
  • Monitoring of extrapyramidal side-effects and other adverse events.

Related Experiment Videos

Main Results:

  • Olanzapine demonstrated efficacy comparable to haloperidol for positive symptoms.
  • Olanzapine showed superior efficacy in improving negative symptoms.
  • Significantly fewer extrapyramidal side-effects were observed with olanzapine compared to haloperidol.
  • Common adverse events included somnolence and weight gain.

Conclusions:

  • Olanzapine is an effective atypical neuroleptic for schizophrenia.
  • It offers an improved side effect profile regarding extrapyramidal symptoms.
  • Olanzapine may be a valuable option for treatment-resistant schizophrenia.